100 related articles for article (PubMed ID: 28106922)
81. Hormone therapy and risk of venous thromboembolism among postmenopausal women in Taiwan - a 10-year nationwide population-based study.
Lee CH; Cheng CL; Kao Yang YH; Lin LJ
Circ J; 2015; 79(5):1107-14. PubMed ID: 25753572
[TBL] [Abstract][Full Text] [Related]
82. Risk factors for recurrent venous thromboembolism in young and middle-aged women.
Ljungqvist M; Sonnevi K; Bergendal A; Holmström M; Kieler H; Lärfars G
Thromb Res; 2014 May; 133(5):762-7. PubMed ID: 24613699
[TBL] [Abstract][Full Text] [Related]
83. Risk of recurrent venous thromboembolism among young women after a first event while exposed to combined oral contraception versus not exposed to: a cohort study.
Le Moigne E; Delluc A; Tromeur C; Nowak E; Mottier D; Lacut K; Le Gal G
Thromb Res; 2013 Jul; 132(1):51-5. PubMed ID: 23786893
[TBL] [Abstract][Full Text] [Related]
84. Recurrent venous thromboembolism after pregnancy-associated versus unprovoked thromboembolism.
White RH; Chan WS; Zhou H; Ginsberg JS
Thromb Haemost; 2008 Aug; 100(2):246-52. PubMed ID: 18690344
[TBL] [Abstract][Full Text] [Related]
85. Outcome after discontinuing anticoagulant therapy in women with venous thromboembolism during hormonal use.
Blanco-Molina Á; Trujillo-Santos J; Pesavento R; Rosa V; Falgá C; Tolosa C; Mazzolai L; Sampériz Á; Duce R; Monreal M;
Thromb Res; 2017 Mar; 151 Suppl 1():S6-S10. PubMed ID: 28262237
[TBL] [Abstract][Full Text] [Related]
86. Using case-control studies for prescribing research.
Mant J; Vessey M
J Clin Pharm Ther; 2002 Feb; 27(1):67-74. PubMed ID: 11846863
[TBL] [Abstract][Full Text] [Related]
87. Recurrence risk of venous thromboembolism and hormone use in women from England: a cohort study using clinical practice research datalink.
Kiconco S; Abdul Sultan A; Grainge MJ
Br J Haematol; 2017 Apr; 177(1):127-135. PubMed ID: 28106922
[TBL] [Abstract][Full Text] [Related]
88. Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism.
Douketis J; Tosetto A; Marcucci M; Baglin T; Cushman M; Eichinger S; Palareti G; Poli D; Tait RC; Iorio A
Ann Intern Med; 2010 Oct; 153(8):523-31. PubMed ID: 20956709
[TBL] [Abstract][Full Text] [Related]
89. How do you decide on hormone replacement therapy in women with risk of venous thromboembolism?
Lekovic D; Miljic P; Dmitrovic A; Thachil J
Blood Rev; 2017 May; 31(3):151-157. PubMed ID: 27998619
[TBL] [Abstract][Full Text] [Related]
90. Venous thromboembolism associated with pregnancy and hormonal therapy.
Jacobsen AF; Sandset PM
Best Pract Res Clin Haematol; 2012 Sep; 25(3):319-32. PubMed ID: 22959548
[TBL] [Abstract][Full Text] [Related]
91. The incidence of first venous thromboembolism in and around pregnancy using linked primary and secondary care data: a population based cohort study from England and comparative meta-analysis.
Abdul Sultan A; Tata LJ; Grainge MJ; West J
PLoS One; 2013; 8(7):e70310. PubMed ID: 23922975
[TBL] [Abstract][Full Text] [Related]
92.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
93.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
94.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
95.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
96.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
97.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
98.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
99.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
100.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
